Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

4 API Suppliers, 1 USDMF, 1 JDMF, 1 KDMF, 1 NDC API, 2 Listed Suppliers

4 API Suppliers
1 USDMF
1 JDMF
1 KDMF
1 NDC API
2 Listed Suppliers

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers, 1 FDA Orange Book

1 FDF Dossiers
1 FDA Orange Book

DIGITAL CONTENT

2 NEWS #PharmaBuzz

media
2 NEWS #PharmaBuzz

MARKET PLACE

7 APIs

marketPlace
7 APIs

PATENTS & EXCLUSIVITIES

11 US Patents, 1 US Exclusivities

patents
11 US Patents
1 US Exclusivities

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

3DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 1187451-19-9, De-117, Omidenepag isopropyl [usan], G0g0h52u6k, Propan-2-yl n-(6-((n-((4-(1h-pyrazol-1-yl)phenyl)methyl)pyridine-3-sulfonamido)methyl)pyridin-2-yl)glycinate, Omidenepag isopropyl (jan)

Molecular Formula

C₂₆H₂₈N₆O₄S

Molecular Weight

520.6 g/mol

InChI Key

VIQCWEGEHRBLAC-UHFFFAOYSA-N

FDA UNII

G0G0H52U6K

Omidenepag isopropyl is under investigation in clinical trial NCT02179008 (Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension).

1 2D Structure

Omidenepag Isopropyl

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

propan-2-yl 2-[[6-[[(4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]pyridin-2-yl]amino]acetate

2.1.2 InChI

InChI=1S/C26H28N6O4S/c1-20(2)36-26(33)17-28-25-8-3-6-22(30-25)19-31(37(34,35)24-7-4-13-27-16-24)18-21-9-11-23(12-10-21)32-15-5-14-29-32/h3-16,20H,17-19H2,1-2H3,(H,28,30)

2.1.3 InChI Key

VIQCWEGEHRBLAC-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC(C)OC(=O)CNC1=CC=CC(=N1)CN(CC2=CC=C(C=C2)N3C=CC=N3)S(=O)(=O)C4=CN=CC=C4

2.2 Other Identifiers

2.2.1 UNII

G0G0H52U6K

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Glycine, N-(6-((((4-(1h-pyrazol-1-yl)phenyl)methyl)(3-pyridinylsulfonyl)amino)methyl)-2-pyridinyl)-, 1-methylethyl Ester

2. Isopropyl N-(6-(((4-(1h-pyrazol-1-yl)benzyl)(3-pyridinylsulfonyl)amino)methyl)-2-pyridinyl)glycinate

2.3.2 Depositor-Supplied Synonyms

1. 1187451-19-9

2. De-117

3. Omidenepag Isopropyl [usan]

4. G0g0h52u6k

5. Propan-2-yl N-(6-((n-((4-(1h-pyrazol-1-yl)phenyl)methyl)pyridine-3-sulfonamido)methyl)pyridin-2-yl)glycinate

6. Omidenepag Isopropyl (jan)

7. Omidenepag Isopropyl [jan]

8. Glycine, N-(6-((((4-(1h-pyrazol-1-yl)phenyl)methyl)(3-pyridinylsulfonyl)amino)methyl)-2-pyridinyl)-, 1-methylethyl Ester

9. Glycine, N-[6-[[[[4-(1h-pyrazol-1-yl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl]-2-pyridinyl]-, 1-methylethyl Ester

10. Eybelis (tn)

11. Unii-g0g0h52u6k

12. Chembl4297666

13. Schembl15414827

14. Tqr1222

15. Dtxsid001106409

16. Bcp26206

17. Ex-a4371

18. Bdbm50506549

19. Omidenepag Isopropyl [who-dd]

20. At36244

21. Db15071

22. Sb18739

23. Hy-111406

24. Cs-0040499

25. Omdi;de-117; De 117; De117

26. D10966

27. Q27896252

28. Isopropyl 2-((6-((n-(4-(1h-pyrazol-1-yl)benzyl)pyridine-3-sulfonamido)methyl)pyridin-2-yl)amino)acetate

29. N-[6-[[[[4-(1h-pyrazol-1-yl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl]-2-pyridinyl]glycine 1-methylethyl Ester

30. Propan-2-yl 2-[[6-[[(4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]pyridin-2-yl]amino]acetate

2.4 Create Date

2009-10-19

3 Chemical and Physical Properties

Molecular Formula	C₂₆H₂₈N₆O₄S
Molecular Weight	520.6 g/mol
XLogP3	3
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	9
Rotatable Bond Count	12
Exact Mass	520.18927457 g/mol
Monoisotopic Mass	520.18927457 g/mol
Topological Polar Surface Area	128 Å²
Heavy Atom Count	37
Formal Charge	0
Complexity	814
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1